v_diretrizes_brasileira_hipertensao_arterial_2006
50 pág.

v_diretrizes_brasileira_hipertensao_arterial_2006

Disciplina:Anatomia Humana14.813 materiais734.926 seguidores
Pré-visualização32 páginas
inhibitor benazepril on the progression of chro�
nic renal ins�fficiency�� N Engl J Med �������334���3�–4���

�78�� Giatra I, La� J, Levey AS�� Effect of angiotensin�converting enzyme inhibitors on the progres�
sion of non�diabetic renal disease�� a meta�analysis of randomized trials�� Ann Intern Med
���7���27��337–4���

�7��� Bakris GL, Weir MR�� Angiotensin�converting enzyme inhibitor�associated elevations in ser�m
creatinine�� is this a ca�se for concern? Arch Intern Med 2000�����0�������8���3��

�80�� Pitt B, Poole�Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger
G, Klinger GH, Neaton J, Sharma D, Thiyagarajan B�� Effects of losartan compared with cap�
topril on mortality in patients with symptomatic heart fail�re�� randomized trial� the Losartan
Heart Fail�re S�rvival St�dy – ELITE II�� Lancet 2000��3������82–7��

�8��� Cohn JN, Tognoni G on behalf of Valsartan Heart Fail�re Trial Investigators�� A randomized
trial of the angiotensinreceptor blocker valsartan in chronic heart fail�re�� N Engl J Med
200���34������7–7���

�82�� Strippoli GF, Craig M, Deeks JJ, Schena FP, Craig FC�� Effects of angiotensin convert enzime
inhibitors and angiotensin II receptor antagonists on mortality and renal o�tcomes in diabetic
nephropathy�� systematic review�� BMJ 2004�����32���

�83�� Stra�ss MH, Lonn EM, Verma S�� Is the j�ry o�t? Class specif differences on coronary co��
tcomes with ACE�Inhibitors and ARBs�� Insight form meta�anlysis and the Blood Press�re
Lowreing Treatment Trialist Clollaboration E�r Heart J 200���2����23����3��

�84�� T�rnb�ll F�� Blood press�re�independet effects for agents inhibiting the renin�angiotens sys�
tem�� Program and abstracts from the Fifteenth E�ropean Meeting on Hypertension, J�ne
�7�2�, Milan, Italy�� Plenary Session �http��//www��medscape��com/viewarticle/�072�3,200����

�8��� Che�ng BM, Che�ng GT, La�der IJ, La� CP, K�mana CR�� Meta�analysis of large o�tcome trials
of angiotensin receptor blockers in hypertension�� J H�m Hypertens 200���� 20��37�43��

�8���� Ab�issa H, Jones PG, Marso SP, O’Keefe JH Jr�� Angiotensin�converting enzyme inhibitors or
angiotensin receptor blockers for prevention of type 2 diabetes�� a meta�analysis of randomi�
zed clinical trials�� J Am Coll Cardiol 200���4����82������

�87�� B�snello RG, Melchior R, Faccin C, Vettori D, Petter J, Moreira LB, F�chs FD�� Características
associadas ao abandono do acompanhamento de pacientes hipertensos atendidos em �m
amb�latório de referência�� Arq Bras Cardiol 200���7���� 34�–����

�88�� Pierin AMG, Mion Jr D, F�k�shima J, Pinto AR, Kaminaga M�� O perfil de �m gr�po de pes�
soas hipertensas de acordo com conhecimento e gravidade da doença�� Rev Esc Enf USP
200���3�����–8��

�8��� Lessa I, Fonseca J�� Raça, aderência ao tratamento e/o� cons�ltas e controle da hipertensão
arterial�� Arq Bras Cardiol ���7����8�� 443–���

��0�� Strelec MAM, Pierin AMG, Mion Jr D�� A infl�ência do conhecimento sobre a doenças e
atit�de frente à tomada dos remédios no controle da hipertensão arterial�� Arq Bras Cardiol
2003��8���34��3�4��

����� G�s I, Harzheim E, Zaslavsky C, Medina C, G�s M�� Prevalência, reconhecimento e con�
trole da hipertensão arterial sistêmica no Estado do Rio Grande do S�l�� Arq Bras Cardiol
2004��83�����424�428��

��2�� Pierin AMG, Strelec MAAM, Mion Jr�� D�� O desafio do controle da hipertensão arterial e a
adesão ao tratamento�� In�� Pierin AMG�� Hipertensão arterial�� �ma proposta para o c�idar��
São Pa�lo�� Ed�� Manole�� 2004�� p�� 27��28���

��3�� Cooper RS�� Ka�fman JS�� Race and hypertension�� science and nescience�� Hypertension
���8��32�����8�3�����

��4�� Brewster LM�� van Montfrans GA�� Kleijnen J�� Systematic review�� antihypertensive dr�g
therapy in black patients�� Ann Intern Med 2004���4��8������4�27��

����� Somes GW, Pahor M, Shorr RI, C�shman WC, Applegate WB�� The role of diastolic blood
press�re when treating isolated systolic hypertension�� Arch Int Med �����������2004–
200���

������ Hansson L, Lindholm LH, Ekbom T, Dahlöf B, Lanke J, Schersten B, Wester PO, Hedner T,
de Faire U�� STOPHypertension�2 st�dy gro�p�� Randomised trial of old and new antihyper�
tensive dr�gs in elderly patients�� cardiovasc�lar mortality and morbidity the Swedish Trial
in Old Patients with Hypertension�2 st�dy�� Lancet, 2000��3�4���7��–����

��7�� The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Gro�p�� Major
o�tcomes in high�risk hypertensive patients randomized to angiotensin�converting enzyme
inhibitor or calci�m channel blocker vs di�retic�� The Antihypertensive and Lipid�Lowering
treatment to prevent Heart Attack Trial �ALLHAT��� JAMA 2002��288��2�8�–2��7��

��8�� Lithell H, Hansson L, Skogg I, Elmfeldt D, Hofman A, Olofsson B, et al�� for the SCOPE St�dy
Gro�p�� The St�dy on Cognition and Prognosis in the Elderly �SCOPE��� Principal res�lts of a
randomised do�ble�blind intervention trial�� J Hypertens 2003��2���87�–88����

����� Forette F�� Se�x ML�� Staessen JA�� Thijs L�� Babarskiene MR�� Babean� S�� Bossini A�� Fagard
R�� Gil�Extremera B�� Laks T�� Kobalava Z�� Sarti C�� T�omilehto J�� Vanhanen H�� Webster J��

47

Yodfat Y�� Birkenhager WH�� The prevention of dementia with antihypertensive treatment��
new evidence from the Systolic Hypertension in E�rope �Syst�E�r� st�dy�� Arch Intern Med
2002�����2��8���204����2��

200�� G�eyffier F, B�lpitt C, Boissel JP, Schron E, Ekbom T, Fagard R, et al�� Antihypertensive dr�gs in
very old people�� a s�bgro�p analysis of randomised controlled trials�� Lancet ������3�3��7�3–
7����� �metanálise�

20��� Rosa AA, Ribeiro FP�� Hipertensão arterial na infância e adolescência�� fatores de terminantes��
J Pediat ������7���7��82��

202�� Vessey M�� Painter R�� Yeates D�� Mortality in relation to oral contraceptive �se and cigarette
smoking�� Lancet 2003��3��2��37�����8������

203�� Baillargeon JP�� McClish DK�� Essah PA�� Nestler JE�� Association between the C�rrent Use of
Low�Dose Oral Contraceptives and Cardiovasc�lar Arterial Disease�� A Meta�Analysis�� J Clin
Endocrinol Metab 200����0�7���38��3�70��

204�� Rosso�w JE�� Anderson GL�� Prentice RL�� LaCroix AZ�� Kooperberg C�� Stefanick ML�� Jack�
son RD�� Beresford SA�� Howard BV�� Johnson KC�� Kotchen JM�� Ockene J�� Risks and benefits
of estrogen pl�s progestin in healthy postmenopa�sal women�� principal res�lts From the
Women’s Health Initiative randomized controlled trial�� JAMA 2002��288�3���32��33��

20��� Osório�Wender MC, Vitola D, Spritzer PM�� Perc�taneo�s�7beta�estradiol replacement the�
rapy in hypertensive postmenopa�sal women�� Braz J Med Biol Res, ���8��30���047–�3��

20���� H�lley S�� Grady D�� B�sh T�� F�rberg C�� Herrington D�� Riggs B�� Vittinghoff E�� Randomized
trial of estrogen pl�s progestin for secondary prevention of coronary heart disease in post�
menopa�sal women�� Heart and Estrogen/progestin Replacement St�dy �HERS� Research
Gro�p�� JAMA ���8��280�7�����0���3��

207�� Report of the National High Blood Press�re Ed�cation Program Working Gro�p on High
Blood Press�re inPregnancy�� Am J Obstet Gynecol 2000���83��S�–S22��

208�� Briggs GG, Freeman RK, Yaffee SJ�� Dr�gs in pregnancyand lactation�� a reference g�ide to
fetal and neonatal risk�� �th ed�� Baltimore �MD��� Williams and Wilkins, ���8��

20��� I Diretriz Brasileira de Diagnóstico e Tratamento da Síndrome Metabólica�� Arq�� Bras�� Car�
diol 200��� 84 �S�pl�� I�����28��

2�0�� Lazar�s JM, Bo�rgoignie JJ, B�ckalew VM, Greene T, Levey AS, Milas NC, Paranandi L,
Peterson JC, Por�sh JG, Ra�ch S, So�cie JM, Stollar C�� Achievement and safety of a low
blood press�re goal in chronic renal disease�� The Modification of Diet in Renal Disease
St�dy Gro�p�� Hypertension ���7��2�����4���

2���� Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL�� Hypertension and antihypertensi�
ve therapy as risk factors